Refine
Year of publication
- 2020 (12) (remove)
Document Type
- Article (12)
Language
- English (12)
Has Fulltext
- yes (12)
Is part of the Bibliography
- no (12)
Keywords
- macrophage (3)
- breast cancer (2)
- cancer (2)
- psoriasis (2)
- renal cell carcinoma (2)
- Cancer (1)
- Cell death and immune response (1)
- Chronic inflammation (1)
- FTMT (1)
- Ferritinophagy (1)
- Ferroptosis (1)
- Hypoxia (1)
- IL-1β (1)
- Immunology (1)
- Iron (1)
- JNK (1)
- Macrophages (1)
- Mφs (1)
- NCOA4 (1)
- NLRP3 inflammasomes (1)
- RNA therapeutics (1)
- S1PR4 (1)
- Sterols (1)
- alcoholic hepatitis (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- carcinoma (1)
- chelation therapy (1)
- chemotherapy (1)
- chronic myeloid leukemia (1)
- cytotoxic lymphocytes (1)
- flow cytometry (1)
- immune checkpoint (1)
- immunotherapy (1)
- inflammation (1)
- inflammation (1)
- iron (1)
- lipoxin A4 (1)
- metabolic reprogramming (1)
- miR-6862-5p (1)
- microRNA (1)
- proteomics (1)
- resolution of inflammation (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- sphingosine-1-phosphate (1)
- transcriptome (1)
- tumor microenvironment (1)
- tyrosine kinase inhibitors. (1)
Institute
- Medizin (12) (remove)
Recent studies suggested an important contribution of sphingosine-1-phospate (S1P) signaling via its specific receptors (S1PRs) in the production of pro-inflammatory mediators such as Interleukin (IL)-1β in cancer and inflammation. In an inflammation-driven cancer setting, we previously reported that myeloid S1PR1 signaling induces IL-1β production by enhancing NLRP3 (NOD-, LRR- and Pyrin Domain-Containing Protein 3) inflammasome activity. However, the autocrine role of S1P and enzymes acting on the S1P rheostat in myeloid cells are unknown. Using human and mouse macrophages with pharmacological or genetic intervention we explored the relative contribution of sphingosine kinases (SPHKs) in NLRP3 inflammasome activity regulation. We noticed redundancy in SPHK1 and SPHK2 activities towards macrophage NLRP3 inflammasome transcriptional induction and IL-1β secretion. However, pharmacological blockade of both kinases in unison completely abrogated NLRP3 inflammasome induction and IL-1β secretion. Interestingly, human and mouse macrophages demonstrate varied responses towards SPHKs inhibition and IL-1β secretion. Clinical datasets of renal cell carcinoma and psoriasis patients showed a positive correlation between enzymes affecting the S1P rheostat with NLRP3 inflammasome components expression, which corroborates our finding. Our data provide a better understanding on the role of SPHKs and de novo synthesized S1P in macrophage NLRP3 inflammasome activation
The nuclear factor kappa beta (NFκB) signaling pathway plays an important role in liver homeostasis and cancer development. Tax1-binding protein 1 (Tax1BP1) is a regulator of the NFκB signaling pathway, but its role in the liver and hepatocellular carcinoma (HCC) is presently unknown. Here we investigated the role of Tax1BP1 in liver cells and murine models of HCC and liver fibrosis. We applied the diethylnitrosamine (DEN) model of experimental hepatocarcinogenesis in Tax1BP1+/+ and Tax1BP1−/− mice. The amount and subsets of non-parenchymal liver cells in in Tax1BP1+/+ and Tax1BP1−/− mice were determined and activation of NFκB and stress induced signaling pathways were assessed. Differential expression of mRNA and miRNA was determined. Tax1BP1−/− mice showed increased numbers of inflammatory cells in the liver. Furthermore, a sustained activation of the NFκB signaling pathway was found in hepatocytes as well as increased transcription of proinflammatory cytokines in isolated Kupffer cells from Tax1BP1−/− mice. Several differentially expressed mRNAs and miRNAs in livers of Tax1BP1−/− mice were found, which are regulators of inflammation or are involved in cancer development or progression. Furthermore, Tax1BP1−/− mice developed more HCCs than their Tax1BP1+/+ littermates. We conclude that Tax1BP1 protects from liver cancer development by limiting proinflammatory signaling.